top of page

Deep Pharma Intelligence

New Era in Pharma Analytics

Deep Pharma Intelligence, an analytical subsidiary of Deep Knowledge Group, is a highly specialized think tank in the area of biotech innovation profiling, market intelligence, and biotech development advisory. The company is dedicated to producing powerful data mining and visualization systems, interactive analytics tools, and industry reports offering deep technical insights, market intelligence, and strategic guidance in the high growth and significant opportunity areas.

Global AI in Drug Discovery Platform

AI in DD Mindmap.png

​AI in BioMed Platform

AI in BioMed.png

​AI in Oncology Platform

AI in Oncology Round mm with tables.png

​AI in Diabetes Platform

AI in Diabetes circular static mindmap (1).png

​AI in NeuroTech Platform

AI in Neurotech round mm (1).png

AI in Organoids and Organ-on-a-chip Technologies Platform

Organoids companies Mindmap.png

Global Diabetes Industry Platform

Global Diabetes_edited.jpg

​AI in Drug Discovery in Asia Platform

AI in DD Asia Mindmap_HQ.png

​AI in Cancer Vaccines Platform

HQ_AI in CV MM_2.png

​AI in FemTech Platform

AI in Femtech Round mm (5).png

​Diabetes Industry in GCC Platform

Diabetes GCC.png

AI in Biomarkers Platform

AI in Biomarkers Static Mindmap.png

New Era in Pharma Analytics

Screenshot 2023-05-06 at 17.55.54.png

Cell Therapies in Healthcare  Q1 2023

Screenshot 2023-02-17 at 16.30.45.png

Artificial Intelligence in Nuclear Medicine Q1 2023

Screenshot 2023-01-12 at 4.15.19 PM.png

Artificial Intelligence for Drug Discovery Q4 2022

Screenshot 2023-03-31 at 16.35.51.png

Artificial Intelligence for Drug Discovery Q1 2023

Screenshot 2023-02-14 at 18.41.00.png

World’s AI for Drug Development Landscape: Focus on Asia

Screenshot 2022-12-02 at 14.12.04.png

Modern Technologies for Preclinical and Clinical Optimisation 

bottom of page